C
Phibro Animal Health Corporation
PAHC
$23.64
$0.331.42%
C
Hold
11/7/2024Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 11/7/2024 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from $0.0186 to $0.17.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 11/7/2024 due to a large increase in the growth index, valuation index and total return index. Earnings per share increased from $0.0186 to $0.17.
C
Hold
8/29/2024Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/29/2024 due to a large decline in the valuation index, growth index and efficiency index. Net income declined 91.05% from $8.41M to $752, earnings per share declined from $0.2075 to $0.0186, and total capital declined 0.81% from $793.74M to $787.29M.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/29/2024 due to a large decline in the valuation index, growth index and efficiency index. Net income declined 91.05% from $8.41M to $752, earnings per share declined from $0.2075 to $0.0186, and total capital declined 0.81% from $793.74M to $787.29M.
C
Hold
5/3/2024Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 5/3/2024 due to an increase in the volatility index and total return index.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 5/3/2024 due to an increase in the volatility index and total return index.
C
Hold
2/8/2024Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/8/2024 due to a large increase in the growth index and solvency index. EBIT increased 2,305.37% from -$726 to $16.01M, earnings per share increased from -$0.2 to $0.03, and operating cash flow increased 94.81% from $16.2M to $31.56M.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/8/2024 due to a large increase in the growth index and solvency index. EBIT increased 2,305.37% from -$726 to $16.01M, earnings per share increased from -$0.2 to $0.03, and operating cash flow increased 94.81% from $16.2M to $31.56M.
D
Sell
11/30/2023Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/30/2023 due to a substantial decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.2839 to -$0.2, net income declined 169.71% from $11.5M to -$8.02M, and EBIT declined 103.05% from $23.77M to -$726.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/30/2023 due to a substantial decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.2839 to -$0.2, net income declined 169.71% from $11.5M to -$8.02M, and EBIT declined 103.05% from $23.77M to -$726.
C
Hold
8/29/2023Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/29/2023 due to a decline in the volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/29/2023 due to a decline in the volatility index.
C
Hold
8/14/2023Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 8/14/2023 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 1.45 to 1.47, and debt to equity declined from 1.8 to 1.79.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 8/14/2023 due to an increase in the volatility index, total return index and solvency index. The quick ratio increased from 1.45 to 1.47, and debt to equity declined from 1.8 to 1.79.
C
Hold
2/24/2023Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/24/2023 due to an increase in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/24/2023 due to an increase in the total return index and volatility index.
D
Sell
2/9/2023Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 2/9/2023 due to a decline in the valuation index, efficiency index and volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 2/9/2023 due to a decline in the valuation index, efficiency index and volatility index.
C
Hold
2/6/2023Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/6/2023 due to an increase in the volatility index and solvency index.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/6/2023 due to an increase in the volatility index and solvency index.
D
Sell
11/16/2022Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/16/2022 due to a decline in the volatility index, total return index and valuation index.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/16/2022 due to a decline in the volatility index, total return index and valuation index.
C
Hold
8/25/2022Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/25/2022 due to a decline in the volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 8/25/2022 due to a decline in the volatility index.
C
Hold
7/6/2022Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 7/6/2022 due to an increase in the volatility index and total return index.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 7/6/2022 due to an increase in the volatility index and total return index.
C
Hold
6/21/2022Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 6/21/2022 due to a decline in the volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 6/21/2022 due to a decline in the volatility index.
C
Hold
6/6/2022Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 6/6/2022 due to a noticeable increase in the valuation index, volatility index and dividend index.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 6/6/2022 due to a noticeable increase in the valuation index, volatility index and dividend index.
C
Hold
2/25/2022Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 2/25/2022 due to a noticeable decline in the total return index.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 2/25/2022 due to a noticeable decline in the total return index.
C
Hold
11/3/2021Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 11/3/2021 due to an increase in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 11/3/2021 due to an increase in the total return index and volatility index.
C
Hold
10/19/2021Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 10/19/2021 due to a large decline in the growth index, volatility index and dividend index. Operating cash flow declined 81.53% from $16.63M to $3.07M, and EBIT declined 4.84% from $20.13M to $19.16M.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 10/19/2021 due to a large decline in the growth index, volatility index and dividend index. Operating cash flow declined 81.53% from $16.63M to $3.07M, and EBIT declined 4.84% from $20.13M to $19.16M.
C
Hold
4/13/2021Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 4/13/2021 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 1,484.98% from $1.7M to $26.91M, EBIT increased 26.78% from $15.69M to $19.89M, and total revenue increased 5.61% from $195.19M to $206.15M.
Phibro Animal Health Corporation (PAHC) was upgraded to C from C- on 4/13/2021 due to an increase in the growth index, total return index and volatility index. Operating cash flow increased 1,484.98% from $1.7M to $26.91M, EBIT increased 26.78% from $15.69M to $19.89M, and total revenue increased 5.61% from $195.19M to $206.15M.
C
Hold
1/25/2021Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 1/25/2021 due to an increase in the total return index.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 1/25/2021 due to an increase in the total return index.
D
Sell
1/8/2021Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 1/8/2021 due to a decline in the volatility index, valuation index and dividend index.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 1/8/2021 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
12/22/2020Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 12/22/2020 due to an increase in the volatility index, valuation index and dividend index.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 12/22/2020 due to an increase in the volatility index, valuation index and dividend index.
D
Sell
12/2/2020Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 12/2/2020 due to a decline in the volatility index, valuation index and total return index.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 12/2/2020 due to a decline in the volatility index, valuation index and total return index.
C
Hold
11/16/2020Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 11/16/2020 due to a significant increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.1393 to $0.3, total revenue increased 5.01% from $185.88M to $195.19M, and EBIT increased 3.68% from $15.13M to $15.69M.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 11/16/2020 due to a significant increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.1393 to $0.3, total revenue increased 5.01% from $185.88M to $195.19M, and EBIT increased 3.68% from $15.13M to $15.69M.
D
Sell
8/27/2020Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 8/27/2020 due to a noticeable decline in the growth index, dividend index and efficiency index. Operating cash flow declined 85.61% from $26.95M to $3.88M, net income declined 58.21% from $13.5M to $5.64M, and earnings per share declined from $0.33 to $0.1385.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 8/27/2020 due to a noticeable decline in the growth index, dividend index and efficiency index. Operating cash flow declined 85.61% from $26.95M to $3.88M, net income declined 58.21% from $13.5M to $5.64M, and earnings per share declined from $0.33 to $0.1385.
C
Hold
5/26/2020Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 5/26/2020 due to an increase in the dividend index, valuation index and efficiency index.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 5/26/2020 due to an increase in the dividend index, valuation index and efficiency index.
D
Sell
5/8/2020Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 5/8/2020 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 16.02% from $32.09M to $26.95M, debt to equity increased from 1.75 to 1.88, and the quick ratio declined from 1.51 to 1.45.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 5/8/2020 due to a noticeable decline in the growth index, solvency index and valuation index. Operating cash flow declined 16.02% from $32.09M to $26.95M, debt to equity increased from 1.75 to 1.88, and the quick ratio declined from 1.51 to 1.45.
C
Hold
2/4/2020Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/4/2020 due to a substantial increase in the growth index and volatility index. Operating cash flow increased 998.91% from -$3.57M to $32.09M, earnings per share increased from $0.06 to $0.29, and EBIT increased 73.32% from $11.31M to $19.61M.
Phibro Animal Health Corporation (PAHC) was upgraded to C- from D+ on 2/4/2020 due to a substantial increase in the growth index and volatility index. Operating cash flow increased 998.91% from -$3.57M to $32.09M, earnings per share increased from $0.06 to $0.29, and EBIT increased 73.32% from $11.31M to $19.61M.
D
Sell
11/5/2019Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/5/2019 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 123.99% from $14.88M to -$3.57M, earnings per share declined from $0.2173 to $0.06, and EBIT declined 40.62% from $17.09M to $10.15M.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from C- on 11/5/2019 due to a noticeable decline in the growth index, volatility index and total return index. Operating cash flow declined 123.99% from $14.88M to -$3.57M, earnings per share declined from $0.2173 to $0.06, and EBIT declined 40.62% from $17.09M to $10.15M.
C
Hold
9/3/2019Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 9/3/2019 due to a significant decline in the growth index, valuation index and dividend index. EBIT declined 46.39% from $22.57M to $12.1M, earnings per share declined from $0.3672 to $0.22, and operating cash flow declined 4.95% from $15.65M to $14.88M.
Phibro Animal Health Corporation (PAHC) was downgraded to C- from C on 9/3/2019 due to a significant decline in the growth index, valuation index and dividend index. EBIT declined 46.39% from $22.57M to $12.1M, earnings per share declined from $0.3672 to $0.22, and operating cash flow declined 4.95% from $15.65M to $14.88M.
C
Hold
7/3/2019Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 7/3/2019 due to a decline in the total return index, valuation index and volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 7/3/2019 due to a decline in the total return index, valuation index and volatility index.
C
Hold
6/18/2019Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 6/18/2019 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.36 to $0.3672, and operating cash flow increased 1.94% from $15.36M to $15.65M.
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 6/18/2019 due to a noticeable increase in the growth index, valuation index and dividend index. Earnings per share increased from $0.36 to $0.3672, and operating cash flow increased 1.94% from $15.36M to $15.65M.
C
Hold
11/14/2018Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 11/14/2018 due to a decline in the total return index, volatility index and efficiency index. Net income declined 26.24% from $22.12M to $16.31M.
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 11/14/2018 due to a decline in the total return index, volatility index and efficiency index. Net income declined 26.24% from $22.12M to $16.31M.
C
Hold
10/8/2018Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 10/8/2018 due to an increase in the volatility index and valuation index.
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 10/8/2018 due to an increase in the volatility index and valuation index.
C
Hold
9/21/2018Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 9/21/2018 due to a noticeable decline in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 9/21/2018 due to a noticeable decline in the total return index and volatility index.
C
Hold
8/28/2018Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 8/28/2018 due to a substantial decline in the growth index, solvency index and dividend index. Operating cash flow declined 55.67% from $22.81M to $10.11M, EBIT declined 9.26% from $26.49M to $24.04M, and the quick ratio declined from 1.58 to 1.5.
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 8/28/2018 due to a substantial decline in the growth index, solvency index and dividend index. Operating cash flow declined 55.67% from $22.81M to $10.11M, EBIT declined 9.26% from $26.49M to $24.04M, and the quick ratio declined from 1.58 to 1.5.
B
Buy
5/23/2018Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 5/23/2018 due to an increase in the total return index, solvency index and efficiency index.
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 5/23/2018 due to an increase in the total return index, solvency index and efficiency index.
C
Hold
5/8/2018Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 5/8/2018 due to a decline in the valuation index, growth index and efficiency index. Operating cash flow declined 29.37% from $32.29M to $22.81M.
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 5/8/2018 due to a decline in the valuation index, growth index and efficiency index. Operating cash flow declined 29.37% from $32.29M to $22.81M.
B
Buy
3/13/2018Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 3/13/2018 due to an increase in the growth index and solvency index. Operating cash flow increased 572.29% from $4.8M to $32.29M, EBIT increased 10.09% from $23.04M to $25.36M, and total revenue increased 6.44% from $193.41M to $205.88M.
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 3/13/2018 due to an increase in the growth index and solvency index. Operating cash flow increased 572.29% from $4.8M to $32.29M, EBIT increased 10.09% from $23.04M to $25.36M, and total revenue increased 6.44% from $193.41M to $205.88M.
C
Hold
11/9/2017Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 11/9/2017 due to a significant decline in the total return index.
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 11/9/2017 due to a significant decline in the total return index.
B
Buy
8/31/2017Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to B- from B on 8/31/2017 due to a decline in the growth index and valuation index. Operating cash flow declined 63.39% from $37.08M to $13.58M, and earnings per share declined from $0.59 to $0.3801.
Phibro Animal Health Corporation (PAHC) was downgraded to B- from B on 8/31/2017 due to a decline in the growth index and valuation index. Operating cash flow declined 63.39% from $37.08M to $13.58M, and earnings per share declined from $0.59 to $0.3801.
B
Buy
8/9/2017Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B from B- on 8/9/2017 due to a major increase in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was upgraded to B from B- on 8/9/2017 due to a major increase in the total return index and volatility index.
B
Buy
6/12/2017Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 6/12/2017 due to a noticeable increase in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 6/12/2017 due to a noticeable increase in the total return index and volatility index.
C
Hold
5/26/2017Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 5/26/2017 due to a decline in the growth index, valuation index and solvency index.
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B- on 5/26/2017 due to a decline in the growth index, valuation index and solvency index.
B
Buy
5/11/2017Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 5/11/2017 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from $0.34 to $0.59, operating cash flow increased 41.1% from $26.28M to $37.08M, and debt to equity declined from 2.92 to 2.22.
Phibro Animal Health Corporation (PAHC) was upgraded to B- from C+ on 5/11/2017 due to a significant increase in the growth index, total return index and solvency index. Earnings per share increased from $0.34 to $0.59, operating cash flow increased 41.1% from $26.28M to $37.08M, and debt to equity declined from 2.92 to 2.22.
C
Hold
9/16/2016Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 9/16/2016 due to an increase in the efficiency index, solvency index and total return index. Debt to equity declined from 4.72 to 3.9.
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 9/16/2016 due to an increase in the efficiency index, solvency index and total return index. Debt to equity declined from 4.72 to 3.9.
C
Hold
5/4/2016Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 5/4/2016 due to a decline in the volatility index and total return index.
Phibro Animal Health Corporation (PAHC) was downgraded to C from C+ on 5/4/2016 due to a decline in the volatility index and total return index.
C
Hold
3/11/2016Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
Phibro Animal Health Corporation (PAHC) was downgraded to C+ from B+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
B
Buy
2/25/2016Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to B+ from A- on 2/25/2016 due to a decline in the total return index, solvency index and volatility index.
Phibro Animal Health Corporation (PAHC) was downgraded to B+ from A- on 2/25/2016 due to a decline in the total return index, solvency index and volatility index.
A
Buy
2/10/2016Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to A- from B on 2/10/2016 due to a large increase in the solvency index, growth index and valuation index. Earnings per share increased from $0.47 to $0.75, debt to equity declined from 13.55 to 5.72, and total revenue increased 2.49% from $187.12M to $191.77M.
Phibro Animal Health Corporation (PAHC) was upgraded to A- from B on 2/10/2016 due to a large increase in the solvency index, growth index and valuation index. Earnings per share increased from $0.47 to $0.75, debt to equity declined from 13.55 to 5.72, and total revenue increased 2.49% from $187.12M to $191.77M.
B
Buy
1/25/2016Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B from D+ on 01/25/2016.
Phibro Animal Health Corporation (PAHC) was upgraded to B from D+ on 01/25/2016.
D
Sell
1/22/2016Downgrade
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from B on 1/22/2016 due to a decline in the efficiency index.
Phibro Animal Health Corporation (PAHC) was downgraded to D+ from B on 1/22/2016 due to a decline in the efficiency index.
B
Buy
5/15/2015Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to B from C+ on 5/15/2015 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 150.85% from $8.4M to $21.08M, net income increased 26.1% from $15.41M to $19.43M, and earnings per share increased from $0.39 to $0.49.
Phibro Animal Health Corporation (PAHC) was upgraded to B from C+ on 5/15/2015 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 150.85% from $8.4M to $21.08M, net income increased 26.1% from $15.41M to $19.43M, and earnings per share increased from $0.39 to $0.49.
C
Hold
2/11/2015Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 2/11/2015 due to a major increase in the valuation index, volatility index and efficiency index. Total capital increased 1.2% from $310.27M to $313.98M.
Phibro Animal Health Corporation (PAHC) was upgraded to C+ from C on 2/11/2015 due to a major increase in the valuation index, volatility index and efficiency index. Total capital increased 1.2% from $310.27M to $313.98M.
C
Hold
11/14/2014Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to C from D+ on 11/14/2014 due to a significant increase in the growth index, efficiency index and solvency index. EBIT increased 36.39% from $18.41M to $25.11M, debt to equity declined from 19.1 to 13.36, and the quick ratio increased from 1.12 to 1.22.
Phibro Animal Health Corporation (PAHC) was upgraded to C from D+ on 11/14/2014 due to a significant increase in the growth index, efficiency index and solvency index. EBIT increased 36.39% from $18.41M to $25.11M, debt to equity declined from 19.1 to 13.36, and the quick ratio increased from 1.12 to 1.22.
D
Sell
10/31/2014Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to D+ from E+ on 10/31/2014 due to an increase in the volatility index, solvency index and total return index.
Phibro Animal Health Corporation (PAHC) was upgraded to D+ from E+ on 10/31/2014 due to an increase in the volatility index, solvency index and total return index.
E
Sell
10/1/2014Upgraded
Phibro Animal Health Corporation (PAHC) was upgraded to E+ from E on 10/1/2014 due to a significant increase in the total return index and volatility index.
Phibro Animal Health Corporation (PAHC) was upgraded to E+ from E on 10/1/2014 due to a significant increase in the total return index and volatility index.
E
Sell
7/8/2014None
Phibro Animal Health Corporation (PAHC) was downgraded to E from U on 07/08/2014.
Phibro Animal Health Corporation (PAHC) was downgraded to E from U on 07/08/2014.
NASDAQ
03/07/2025 3:00PM Eastern
Quotes delayed
